ID   KCNA3_RAT               Reviewed;         525 AA.
AC   P15384;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 2.
DT   02-OCT-2024, entry version 182.
DE   RecName: Full=Potassium voltage-gated channel subfamily A member 3;
DE   AltName: Full=RCK3;
DE   AltName: Full=RGK5;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv1.3;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv3;
GN   Name=Kcna3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TRANSPORTER ACTIVITY.
RC   TISSUE=Brain;
RX   PubMed=2555158; DOI=10.1002/j.1460-2075.1989.tb08483.x;
RA   Stuehmer W., Ruppersberg J.P., Schroerter K.H., Sakmann B., Stocker M.,
RA   Giese K.P., Perschke A., Baumann A., Pongs O.;
RT   "Molecular basis of functional diversity of voltage-gated potassium
RT   channels in mammalian brain.";
RL   EMBO J. 8:3235-3244(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND TRANSPORTER ACTIVITY.
RC   TISSUE=Brain;
RX   PubMed=2361015; DOI=10.1016/0896-6273(90)90146-7;
RA   Swanson R., Marshall J., Smith J., Williams J., Boyle M.B., Folander K.,
RA   Luneau C.J., Antanavage J., Oliva C., Buhrow S.A., Bennett C., Stein R.B.,
RA   Kaczmarek L.M.;
RT   "Cloning and expression of cDNA and genomic clones encoding three delayed
RT   rectifier potassium channels in rat brain.";
RL   Neuron 4:929-939(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND TRANSPORTER ACTIVITY.
RC   TISSUE=Lymphocyte;
RX   PubMed=2351830;
RA   Douglass J., Osborne P.B., Cai Y.C., Wilkinson M., Christie M.J.,
RA   Adelman J.P.;
RT   "Characterization and functional expression of a rat genomic DNA clone
RT   encoding a lymphocyte potassium channel.";
RL   J. Immunol. 144:4841-4850(1990).
RN   [4]
RP   INTERACTION WITH DLG1; DLG2 AND DLG4, AND PDZ-BINDING MOTIF.
RX   PubMed=7477295; DOI=10.1038/378085a0;
RA   Kim E., Niethammer M., Rothschild A., Jan Y.N., Sheng M.;
RT   "Clustering of Shaker-type K+ channels by interaction with a family of
RT   membrane-associated guanylate kinases.";
RL   Nature 378:85-88(1995).
RN   [5]
RP   FUNCTION, TRANSPORTER ACTIVITY, PHOSPHORYLATION AT TYR-449, AND MUTAGENESIS
RP   OF TYR-449.
RX   PubMed=8774427; DOI=10.1523/jneurosci.16-05-01581.1996;
RA   Holmes T.C., Fadool D.A., Levitan I.B.;
RT   "Tyrosine phosphorylation of the Kv1.3 potassium channel.";
RL   J. Neurosci. 16:1581-1590(1996).
RN   [6]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, AND INTERACTION WITH
RP   KCEN4.
RX   PubMed=19773357; DOI=10.1242/jcs.056689;
RA   Sole L., Roura-Ferrer M., Perez-Verdaguer M., Oliveras A., Calvo M.,
RA   Fernandez-Fernandez J.M., Felipe A.;
RT   "KCNE4 suppresses Kv1.3 currents by modulating trafficking, surface
RT   expression and channel gating.";
RL   J. Cell Sci. 122:3738-3748(2009).
RN   [7]
RP   GLYCOSYLATION AT ASN-229, LACK OF GLYCOSYLATION AT ASN-228, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=22613618; DOI=10.1111/j.1742-4658.2012.08642.x;
RA   Zhu J., Yan J., Thornhill W.B.;
RT   "N-glycosylation promotes the cell surface expression of Kv1.3 potassium
RT   channels.";
RL   FEBS J. 279:2632-2644(2012).
RN   [8]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, AND INTERACTION WITH
RP   KCNE4 AND SEC24D.
RX   PubMed=27802162; DOI=10.1242/jcs.191650;
RA   Sole L., Roig S.R., Vallejo-Gracia A., Serrano-Albarras A.,
RA   Martinez-Marmol R., Tamkun M.M., Felipe A.;
RT   "The C-terminal domain of Kv1.3 regulates functional interactions with the
RT   KCNE4 subunit.";
RL   J. Cell Sci. 129:4265-4277(2016).
RN   [9]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, SUBUNIT, AND
RP   INTERACTION WITH KCEN4.
RX   PubMed=32370164; DOI=10.3390/cells9051128;
RA   Sole L., Sastre D., Colomer-Molera M., Vallejo-Gracia A., Roig S.R.,
RA   Perez-Verdaguer M., Lillo P., Tamkun M.M., Felipe A.;
RT   "Functional Consequences of the Variable Stoichiometry of the Kv1.3-KCNE4
RT   Complex.";
RL   Cells 9:0-0(2020).
CC   -!- FUNCTION: Mediates the voltage-dependent potassium ion permeability of
CC       excitable membranes. Assuming opened or closed conformations in
CC       response to the voltage difference across the membrane, the protein
CC       forms a potassium-selective channel through which potassium ions may
CC       pass in accordance with their electrochemical gradient.
CC       {ECO:0000269|PubMed:19773357, ECO:0000269|PubMed:2351830,
CC       ECO:0000269|PubMed:2361015, ECO:0000269|PubMed:2555158,
CC       ECO:0000269|PubMed:27802162, ECO:0000269|PubMed:32370164,
CC       ECO:0000269|PubMed:8774427}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=K(+)(in) = K(+)(out); Xref=Rhea:RHEA:29463, ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000269|PubMed:19773357, ECO:0000269|PubMed:2351830,
CC         ECO:0000269|PubMed:2361015, ECO:0000269|PubMed:2555158,
CC         ECO:0000269|PubMed:27802162, ECO:0000269|PubMed:32370164,
CC         ECO:0000269|PubMed:8774427};
CC   -!- ACTIVITY REGULATION: Activity is up-regulated by JAK2.
CC       {ECO:0000250|UniProtKB:P16390}.
CC   -!- SUBUNIT: Homotetramer. Forms heterooligomers with KCNE4 which inhibits
CC       KCNA3 activity by impairing localization to the cell membrane. The
CC       stoichiometry of KCNA3 and KCNE4 in the heterooligomers are 4:1, 4:2,
CC       4:3 or 4:4 respectively. Increasing the number of KCNE4 subunits
CC       steadily slows the activation KCNA3 and decreases its abundance at the
CC       cell membrane. However, a single subunit of KCNE4 is sufficient for the
CC       cooperative enhancement of the inactivating function of the channel
CC       (PubMed:27802162, PubMed:19773357, PubMed:32370164). Interacts with
CC       SEC24D; this interaction is reduced in the presence of KCNE4
CC       (PubMed:27802162). Interacts with DLG1, DLG2 and DLG4 via their PDZ
CC       domains (PubMed:7477295). {ECO:0000269|PubMed:19773357,
CC       ECO:0000269|PubMed:27802162, ECO:0000269|PubMed:32370164,
CC       ECO:0000269|PubMed:7477295}.
CC   -!- INTERACTION:
CC       P15384; P78352: DLG4; Xeno; NbExp=2; IntAct=EBI-631478, EBI-80389;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:19773357,
CC       ECO:0000269|PubMed:22613618, ECO:0000269|PubMed:27802162,
CC       ECO:0000269|PubMed:32370164}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- DOMAIN: The N-terminus may be important in determining the rate of
CC       inactivation of the channel while the tail may play a role in
CC       modulation of channel activity and/or targeting of the channel to
CC       specific subcellular compartments.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at every
CC       third position.
CC   -!- PTM: Phosphorylation on Tyr-449 inhibits its channel activity.
CC       {ECO:0000269|PubMed:8774427}.
CC   -!- PTM: N-glycosylation promotes the cell surface expression.
CC       {ECO:0000269|PubMed:22613618}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. A (Shaker) (TC
CC       1.A.1.2) subfamily. Kv1.3/KCNA3 sub-subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X16001; CAA34132.1; -; mRNA.
DR   EMBL; M30312; AAA42035.1; -; Genomic_DNA.
DR   EMBL; M31744; AAA41500.1; -; Genomic_DNA.
DR   PIR; A43531; A43531.
DR   RefSeq; NP_062143.3; NM_019270.3.
DR   AlphaFoldDB; P15384; -.
DR   SMR; P15384; -.
DR   BioGRID; 248344; 2.
DR   CORUM; P15384; -.
DR   IntAct; P15384; 1.
DR   STRING; 10116.ENSRNOP00000075761; -.
DR   BindingDB; P15384; -.
DR   ChEMBL; CHEMBL4248; -.
DR   GuidetoPHARMACOLOGY; 540; -.
DR   GlyCosmos; P15384; 1 site, No reported glycans.
DR   GlyGen; P15384; 1 site.
DR   iPTMnet; P15384; -.
DR   PhosphoSitePlus; P15384; -.
DR   PaxDb; 10116-ENSRNOP00000024372; -.
DR   ABCD; P15384; 1 sequenced antibody.
DR   Ensembl; ENSRNOT00000092240.2; ENSRNOP00000075761.1; ENSRNOG00000062002.2.
DR   Ensembl; ENSRNOT00000108050.1; ENSRNOP00000096474.1; ENSRNOG00000062002.2.
DR   Ensembl; ENSRNOT00055034614; ENSRNOP00055028042; ENSRNOG00055020274.
DR   Ensembl; ENSRNOT00055034620; ENSRNOP00055028047; ENSRNOG00055020274.
DR   Ensembl; ENSRNOT00060051882; ENSRNOP00060043147; ENSRNOG00060029881.
DR   Ensembl; ENSRNOT00060051896; ENSRNOP00060043158; ENSRNOG00060029881.
DR   Ensembl; ENSRNOT00065039148; ENSRNOP00065031802; ENSRNOG00065022921.
DR   Ensembl; ENSRNOT00065039159; ENSRNOP00065031811; ENSRNOG00065022921.
DR   GeneID; 29731; -.
DR   KEGG; rno:29731; -.
DR   UCSC; RGD:2951; rat.
DR   AGR; RGD:2951; -.
DR   CTD; 3738; -.
DR   RGD; 2951; Kcna3.
DR   eggNOG; KOG1545; Eukaryota.
DR   GeneTree; ENSGT00940000160210; -.
DR   InParanoid; P15384; -.
DR   OMA; INHSAFK; -.
DR   OrthoDB; 1478695at2759; -.
DR   PhylomeDB; P15384; -.
DR   TreeFam; TF313103; -.
DR   Reactome; R-RNO-1296072; Voltage gated Potassium channels.
DR   PRO; PR:P15384; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000062002; Expressed in thymus and 12 other cell types or tissues.
DR   GO; GO:0030424; C:axon; ISO:RGD.
DR   GO; GO:0044305; C:calyx of Held; IDA:SynGO.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0045121; C:membrane raft; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:SynGO.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:SynGO.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IBA:GO_Central.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IMP:RGD.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; IMP:RGD.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0001508; P:action potential; IBA:GO_Central.
DR   GO; GO:0022038; P:corpus callosum development; IEP:RGD.
DR   GO; GO:0021554; P:optic nerve development; IEP:RGD.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; TAS:RGD.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   Gene3D; 1.10.287.70; -; 1.
DR   Gene3D; 1.20.120.350; Voltage-gated potassium channels. Chain C; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003972; K_chnl_volt-dep_Kv1.
DR   InterPro; IPR004050; K_chnl_volt-dep_Kv1.3.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR027359; Volt_channel_dom_sf.
DR   PANTHER; PTHR11537:SF28; POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY A MEMBER 3; 1.
DR   PANTHER; PTHR11537; VOLTAGE-GATED POTASSIUM CHANNEL; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01510; KV13CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01496; SHAKERCHANEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; POZ domain; 1.
DR   SUPFAM; SSF81324; Voltage-gated potassium channels; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Glycoprotein; Ion channel; Ion transport; Lipoprotein;
KW   Membrane; Palmitate; Phosphoprotein; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN           1..525
FT                   /note="Potassium voltage-gated channel subfamily A member
FT                   3"
FT                   /id="PRO_0000053979"
FT   TOPO_DOM        1..184
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        185..203
FT                   /note="Helical; Name=Segment S1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        204..244
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        245..266
FT                   /note="Helical; Name=Segment S2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        267..277
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        278..298
FT                   /note="Helical; Name=Segment S3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        299..312
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        313..331
FT                   /note="Helical; Voltage-sensor; Name=Segment S4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        332..347
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        348..367
FT                   /note="Helical; Name=Segment S5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        368..408
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        409..431
FT                   /note="Helical; Name=Segment S6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        432..525
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          1..23
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          432..525
FT                   /note="Interaction with KCNE4"
FT                   /evidence="ECO:0000269|PubMed:27802162"
FT   MOTIF           394..399
FT                   /note="Selectivity filter"
FT                   /evidence="ECO:0000250|UniProtKB:P63142"
FT   MOTIF           523..525
FT                   /note="PDZ-binding"
FT                   /evidence="ECO:0000269|PubMed:7477295"
FT   SITE            228
FT                   /note="Not glycosylated"
FT                   /evidence="ECO:0000269|PubMed:22613618"
FT   MOD_RES         449
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:8774427"
FT   MOD_RES         470
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000255"
FT   LIPID           267
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        229
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:22613618"
FT   MUTAGEN         449
FT                   /note="Y->F: Loss of phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:8774427"
FT   CONFLICT        106
FT                   /note="F -> L (in Ref. 1; CAA34132)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        181
FT                   /note="G -> R (in Ref. 3; AAA42035)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        430
FT                   /note="V -> L (in Ref. 3; AAA42035)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   525 AA;  58425 MW;  6DA8869D5471C401 CRC64;
     MTVVPGDHLL EPEAAGGGGG DPPQGGCVSG GGCDRYEPLP PALPAAGEQD CCGERVVINI
     SGLRFETQLK TLCQFPETLL GDPKRRMRYF DPLRNEYFFD RNRPSFDAIL YYYQSGGRIR
     RPVNVPIDIF SEEIRFYQLG EEAMEKFRED EGFLREEERP LPRRDFQRQV WLLFEYPESS
     GPARGIAIVS VLVILISIVI FCLETLPEFR DEKDYPASPS QDVFEAANNS TSGASSGASS
     FSDPFFVVET LCIIWFSFEL LVRFFACPSK ATFSRNIMNL IDIVAIIPYF ITLGTELAER
     QGNGQQAMSL AILRVIRLVR VFRIFKLSRH SKGLQILGQT LKASMRELGL LIFFLFIGVI
     LFSSAVYFAE ADDPSSGFNS IPDAFWWAVV TMTTVGYGDM HPVTIGGKIV GSLCAIAGVL
     TIALPVPVIV SNFNYFYHRE TEGEEQAQYM HVGSCQHLSS SAEELRKARS NSTLSKSEYM
     VIEEGGMNHS AFPQTPFKTG NSTATCTTNN NPNSCVNIKK IFTDV
//
